Teva Pharmaceutical Industries Ltd's drug Azilect reduces disability in patients with advanced Parkinson's disease, according to new research published on Friday. Professor Olivier Rascol of University Hospital in Toulouse, France, said a clinical study involving 687 patients showed that adding the once-daily medicine, also known as rasagiline, to therapy with the drug levodopa improved patients' motor function.
Comments
Comments are closed.